CDXS Codexis Inc
- Stocks
- Healthcare
- NASDAQ: CDXS
Price (delayed)
$3.04
Market cap
$251.85M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.97
Enterprise value
$291.46M
Highlights
Codexis's gross profit has decreased by 42% YoY and by 17% QoQ
The debt has grown by 38% YoY
Key stats
What are the main financial stats of CDXS
Market
Valuations
Earnings
Shares outstanding
82.84M
Market cap
$251.85M
Enterprise value
$291.46M
Price to earnings (P/E)
N/A
Price to book (P/B)
5.07
Price to sales (P/S)
5.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.85
Revenue
$49.82M
Gross profit
$35.65M
Operating income
-$67.12M
Net income
-$74.46M
EBIT
-$63.6M
EBITDA
-$55.59M
Free cash flow
-$59.77M
Per share
Balance sheet
Liquidity
EPS
-$0.97
EPS diluted
-$0.97
Free cash flow per share
-$0.73
Book value per share
$0.6
Revenue per share
$0.6
TBVPS
$1.53
Total assets
$128.89M
Total liabilities
$79.26M
Debt
$59.5M
Equity
$49.63M
Working capital
$56.91M
Debt to equity
1.2
Current ratio
3.72
Quick ratio
3.4
Net debt/EBITDA
-0.71
Margins
Efficiency
Dividend
EBITDA margin
-111.6%
Gross margin
71.6%
Net margin
-149.5%
Operating margin
-134.7%
Return on assets
-53.4%
Return on equity
-118.5%
Return on invested capital
-47%
Return on capital employed
-58.9%
Return on sales
-127.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CDXS stock price
How has the Codexis stock price performed over time
Intraday
-2.25%
1 week
7.04%
1 month
27.2%
1 year
-17.84%
YTD
-36.27%
QTD
24.59%
Financial performance
How have Codexis's revenue and profit performed over time
Revenue
$49.82M
Gross profit
$35.65M
Operating income
-$67.12M
Net income
-$74.46M
Gross margin
71.6%
Net margin
-149.5%
The operating margin has dropped by 78% year-on-year and by 37% since the previous quarter
The net margin has plunged by 70% YoY and by 36% from the previous quarter
Codexis's gross profit has decreased by 42% YoY and by 17% QoQ
CDXS's revenue is down by 33% year-on-year and by 16% since the previous quarter
Price vs fundamentals
How does CDXS's price correlate with its fundamentals
Growth
What is Codexis's growth rate over time
Valuation
What is Codexis stock price valuation
P/E
N/A
P/B
5.07
P/S
5.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.85
The EPS has declined by 9% since the previous quarter and by 4.3% year-on-year
The equity has declined by 37% year-on-year and by 26% since the previous quarter
CDXS's price to book (P/B) is 21% higher than its last 4 quarters average of 4.2 but 2.5% lower than its 5-year quarterly average of 5.2
The price to sales (P/S) is 37% lower than the 5-year quarterly average of 8.0 but 17% higher than the last 4 quarters average of 4.3
CDXS's revenue is down by 33% year-on-year and by 16% since the previous quarter
Efficiency
How efficient is Codexis business performance
The return on sales has dropped by 81% year-on-year and by 38% since the previous quarter
Codexis's return on equity has shrunk by 73% YoY and by 28% QoQ
Codexis's return on assets has decreased by 33% YoY and by 18% QoQ
The company's return on invested capital rose by 28% YoY but it fell by 7% QoQ
Dividends
What is CDXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CDXS.
Financial health
How did Codexis financials performed over time
CDXS's total assets is 63% greater than its total liabilities
CDXS's total assets is down by 14% year-on-year and by 14% since the previous quarter
The total liabilities rose by 13% year-on-year but it has declined by 3.4% since the previous quarter
The debt is 20% more than the equity
The company's debt to equity has surged by 118% YoY and by 35% QoQ
The debt has grown by 38% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.